AU1589492A - Starch-based controlled release compositions - Google Patents

Starch-based controlled release compositions

Info

Publication number
AU1589492A
AU1589492A AU15894/92A AU1589492A AU1589492A AU 1589492 A AU1589492 A AU 1589492A AU 15894/92 A AU15894/92 A AU 15894/92A AU 1589492 A AU1589492 A AU 1589492A AU 1589492 A AU1589492 A AU 1589492A
Authority
AU
Australia
Prior art keywords
starch
controlled release
release compositions
based controlled
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15894/92A
Other languages
English (en)
Inventor
Tsun-Ming Chen
Subraman Rao Cherukuri
Mahdi Fawzi
David J. Lentz
Antonio Moroni
Kuchi S Murthy
Galen W Radebaugh
Michael G Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU1589492A publication Critical patent/AU1589492A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
AU15894/92A 1991-03-01 1992-03-02 Starch-based controlled release compositions Abandoned AU1589492A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66417391A 1991-03-01 1991-03-01
US664173 1996-06-14

Publications (1)

Publication Number Publication Date
AU1589492A true AU1589492A (en) 1992-10-06

Family

ID=24664881

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15894/92A Abandoned AU1589492A (en) 1991-03-01 1992-03-02 Starch-based controlled release compositions

Country Status (2)

Country Link
AU (1) AU1589492A (fr)
WO (1) WO1992015285A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292519A (en) * 1992-04-10 1994-03-08 American Maize Technology, Inc. Process for producing a pharmaceutical tablet using a homozygous white starch
JPH09500645A (ja) * 1993-07-22 1997-01-21 ワーナー−ランバート・コンパニー 制御放出タクリン薬物送達システムおよびその製造方法
US5565407A (en) * 1993-12-27 1996-10-15 University Of Kansas Center For Research, Inc. Biologically active agent encapsulated in biodegradable starch/polymer matrices
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
NL9401534A (nl) * 1994-09-21 1996-05-01 Gijsbertus Gerardus Petrus Van Gebruik van zetmeel voor parenterale toepassingen.
NL9401703A (nl) * 1994-10-14 1996-05-01 Rijksuniversiteit Kauwgom.
FR2747306B1 (fr) * 1996-04-15 1998-05-22 Oreal Utilisation d'un polymere hydrocarbone pour la fixation et/ou la liberation prolongee de parfum
EP0992251A1 (fr) * 1998-10-07 2000-04-12 Isotis B.V. Dispositif pour la régénération osseuse d'un équivalent osseux
US6274168B1 (en) 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions
DE19918325A1 (de) * 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
WO2004058152A2 (fr) * 2002-12-16 2004-07-15 Ranbaxy Pharmaceuticals Inc. Composition pharmaceutique a liberation prolongee de phenytoine sodique
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
WO2005115343A2 (fr) 2004-05-28 2005-12-08 Abbott Gmbh & Co. Kg Forme galénique obtenue à partir d'un mélange pulvérulent contenant un pigment inorganique
US9029427B2 (en) * 2005-11-11 2015-05-12 Asahi Kasei Chemicals Corporation Controlled release solid preparation
DE102006055477A1 (de) * 2006-11-24 2008-05-29 Bayer Cropscience Ag Pflanzenschutzgranulate zur Applikation auf die Blattoberfläche
US8486439B2 (en) 2007-03-01 2013-07-16 Bioneedle Technologies Group B.V. Parenteral formulation
US9198869B2 (en) 2013-03-14 2015-12-01 Aimmune Therapeutics, Inc. Manufacture of peanut formulations for oral desensitization
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
CN105012265A (zh) * 2015-08-19 2015-11-04 上海华源安徽锦辉制药有限公司 一种含有苯妥英钠化合物的药物组合物及其制备方法
RU2629595C1 (ru) * 2016-09-08 2017-08-30 федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный медицинский университет имени В.И. Разумовского" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Саратовский ГМУ им. В.И. Разумовского Минздрава России) Препарат для регенерации мягких тканей с антибактериальным эффектом
RU2629596C1 (ru) * 2016-09-08 2017-08-30 федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный медицинский университет имени В.И. Разумовского" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Саратовский ГМУ им. В.И. Разумовского Минздрава России) Порошкообразный препарат с антибактериальным и регенерирующим эффектами
CN113966229A (zh) 2019-05-10 2022-01-21 爱沐疗法公司 用于改善花生过敏患者的生活质量的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG46154A3 (en) * 1983-02-18 1989-10-16 Warner-Lambert Company Llc Method for preparing of capsules
IE66735B1 (en) * 1988-11-03 1996-02-07 Biotec Biolog Naturverpack Thermoplastically workable starch and a method for the manufacture thereof

Also Published As

Publication number Publication date
WO1992015285A1 (fr) 1992-09-17

Similar Documents

Publication Publication Date Title
AU659473B2 (en) Slow release compositions
AU2746992A (en) Controlled release pharmaceutical compositions
AU1589492A (en) Starch-based controlled release compositions
AU6605894A (en) Opiod formulations having extended controlled release
AU3057492A (en) Controlled release flutamide composition
AU1118092A (en) Sustained release compositions
AU5939394A (en) Sustained release compositions
AU2963192A (en) Fullerene-polymer compositions
AU6196394A (en) Controlled release formulation
AU9174391A (en) Fire-extinguishing compositions
AU3432689A (en) Controlled release composition
AU2857092A (en) Polyol compositions
AU1806895A (en) Controlled release composition
AU1700892A (en) Release liner
AU1037792A (en) Plaster composition
AU2980592A (en) Insecticidal compositions
AU3792695A (en) Photoprotection compositions
AU1704292A (en) Polyisocyanate composition
AU7813491A (en) Modified dispersant compositions
AU1013992A (en) Lice-repellant compositions
GB2252043B (en) Controlled release compositions
AU2960892A (en) Immunogen composition
AU2395692A (en) Herbicidal composition
AU1164892A (en) Compositions
AU2962792A (en) Cementitious compositions